Effect of the antidiabetic agent pioglitazone on bone metabolism in rats.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of pharmacological sciences"
DOI: 10.1016/j.jphs.2017.08.004
Abstract: Thiazolidinediones (TZDs) are synthetic peroxisome proliferator-activated receptor gamma (PPARĪ³) agonists used as therapy for type 2 diabetes. However, clinical studies reported that the therapeutic modulation of PPARĪ³ activity using TZDs may induce negative effects on… read more here.
Keywords: metabolism rats; pioglitazone; bone; pioglitazone bone ... See more keywords